The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Current metastatic melanoma treatment patterns in academic oncology.
 
Nrupen Anjan Bhavsar
Research Funding - Dendreon (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
 
Steven Wolf
No Relationships to Disclose
 
Lynn Jackson Howie
No Relationships to Disclose
 
Bradford Richard Hirsch
Consulting or Advisory Role - Astellas Pharma; Genentech; Pfizer; Sandoz
Research Funding - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Genentech; Pfizer; Sandoz
 
Lesley Ann Miller
Employment - GlaxoSmithKline; Sanofi
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Alan Oglesby
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Bhakti Arondekar
No Relationships to Disclose
 
April K. Salama
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst)
 
Amy Pickar Abernethy
Employment - Advoset; AthenaHealth; Flatiron Health; Orange Leaf Associates
Leadership - AAHPM; AAHPM
Stock and Other Ownership Interests - AthenaHealth
Consulting or Advisory Role - ACORN Research; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); Galena Biopharma (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Insys Therapeutics (Inst); KangLaiTe (Inst); Pfizer (Inst)